Navigation Links
MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting

enhanced protection from chemotherapy-induced nausea and vomiting (CINV) observed with Aloxi in clinical trials.

"The data presentations at ASCO demonstrate our commitment to advancing the discovery of clinical attributes that distinguish each of the oncology products in our portfolio," said Mary Lynne Hedley, Ph.D., Executive Vice President and Chief Scientific Officer of MGI PHARMA. "We look forward to advancing the scientific understanding of our product candidates and the presentation of data at future medical meetings."

Aloxi(R) Injection

Study Results on Receptor Interactions of Aloxi Versus Other 5-HT3 Receptor Antagonists

The results of studies characterizing the molecular ligand-receptor interactions of Aloxi and the other 5-HT3 receptor antagonists, ondansetron and granisetron, were reported. Competitive versus allosteric interactions between these agents and the 5-HT(3) receptor were examined in binding experiments using each unlabeled antagonist in competition with ((3)H)-antagonist. Concentrations of ((3)H)-antagonists were representative of the probable concentrations of each antagonist at the receptor site in vivo. Based on a plot of the concentration of unlabeled antagonist needed to observe half maximal binding (IC50) as a function of ((3)H)-antagonist concentration, Aloxi demonstrated dual action suggesting competitive and allosteric interactions with the 5-HT3 receptor. In contrast, ondansetron and granisetron exhibited strictly competitive antagonism.

The Aloxi allosteric interaction with the 5-HT3 receptor indicates that it has additional inhibitory potential at the primary receptor binding site compared to the other 5-HT3 receptor antagonists studied.

Study of a Single Day Combination of Aloxi, Dexamethasone and Aprepitant in Patients Receiving Moderately Emetogenic Chemotherapy

(MEC) Regimens

The results of a study evaluating the efficacy of Aloxi in combination with dexamethasone and apr
'"/>




Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:5/27/2015)... Una presentazione speciale durante la settimana della ... di MERG valutare i successi ottenuti grazie ... svariate popolazioni di pazienti affetti dalla patologia. ... Ronnie Fass , MD della Case Western Reserve University, ... relativi alla terapia Stretta. Un panel di esperti ha ...
(Date:5/27/2015)... Biosensors International Group, Ltd. ("Biosensors " or ... a developer, manufacturer and marketer of innovative medical devices, ... ("Q4 FY15") and fiscal full year ended 31 March ... , Q4 FY15: , Total revenue ... of Fiscal Year 2014 ("Q4 FY14") due to licensing ...
(Date:5/27/2015)... VILLAGE, Nev. , May 27, 2015  PDL ... that John P. McLaughlin , the company,s president ... 2015 Global Healthcare Conference next week in New York ... on Wednesday, June 3, 2015 at 11:30 a.m. EDT. ... webcast of the presentation, go to the Company,s website ...
Breaking Medicine Technology:Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 2Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 3Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 4Biosensors Reports Financial Results for Fiscal Year 2015 2Biosensors Reports Financial Results for Fiscal Year 2015 3Biosensors Reports Financial Results for Fiscal Year 2015 4Biosensors Reports Financial Results for Fiscal Year 2015 5Biosensors Reports Financial Results for Fiscal Year 2015 6Biosensors Reports Financial Results for Fiscal Year 2015 7PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference 2
... , SAN CARLOS, Calif., Nov. 30 ... promotion of Lorianne Masuoka, M.D. to Senior Vice President ... directly to Nektar,s President and Chief Executive Officer, Howard ... highly effective clinical development strategies have been instrumental in ...
... , CHICAGO, Nov. 30 Breast-Specific Gamma Imaging ... high-risk lesions in patients with negative or indeterminate mammographic ... today at the annual meeting of the Radiological Society ... BSGI was conducted as an adjunct diagnostic imaging modality ...
Cached Medicine Technology:Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings 2
(Date:5/27/2015)... Valley, CA (PRWEB) May 27, 2015 For ... Dr. Peyman Ghasri, is now offering discounts on facial fillers. ... year after the age of 18. This lost collagen can ... sunken cheeks, wrinkles and expression lines. Facial fillers are an ... Many people turn to facial fillers to create a softer ...
(Date:5/27/2015)... 27, 2015 Decorview , a ... is offering free design advice to homeowners looking to ... , “Light pollution caused by streetlights, outdoor signs, full ... night’s sleep, said Kim Rush, VP of sales and ... across North America with recently installed LED streetlights– the ...
(Date:5/27/2015)... CRN International, the radio marketing and promotions ... Financial Officer. , Prinner most recently was Principal of ... financial/operational executive positions at telecom and technology services companies ... and SNET. His accounting and consulting career began ... will be able to tap into his experience of ...
(Date:5/27/2015)... May 27, 2015 Altec Products, Inc., ... announced today their Premier Sponsorship of Connections 2015. The ... Hilton on Thursday, May 28th and will deliver to ... well as the roadmap to get there. , ... in the sale, installation and support of Intacct Cloud ...
(Date:5/27/2015)... 27, 2015 With the FCPX LUT ... can quickly and easily add filmic color grades to their ... files. , FCPX LUT Cross Processed Plugin can instantly make ... looks and everything in between. , FCPX LUT Cross Processed ... in many different softwares. With the FCPX LUT Cross Processed ...
Breaking Medicine News(10 mins):Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2Health News:Decorview Helps Homeowners Combat Light Pollution 2Health News:CRN International Names New Chief Financial Officer 2Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 2Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 3Health News:Developers at Pixel Film Studios Release FCPX LUT Cross Processed Plugin for Final Cut Pro X 2
... ABT ),will present at the Citi Investment Research ... C. Freyman, executive vice president,finance and chief financial officer, ... Central time., A live audio webcast of the ... at http://www.abbottinvestor.com . An,archived edition of the presentation ...
... With the economy tight and,sales forces shrinking across ... maintain an effective sales force. Regardless, a company,s ... success going forward. That,success is predicated on establishing ... goals and managing groups in a way,that meets ...
... increase the risk of Alzheimers Disease by as much as ... issue of Obesity Reviews. , But its not just weight ... have an elevated risk of dementia, unlike people who are ... detailed review of 10 international studies published since 1995, covering ...
... staffing company to launch nationally-syndicated television ... ... Access,Nurses announced today a national campaign to change the image of nursing,in ... lives of nurses working on the front lines of modern,healthcare. The show, ...
... May 7 Emageon Inc. (Nasdaq:,EMAG), a leader in ... imaging facilities, will hold its,quarterly conference call to discuss ... at 10:00 AM Eastern Time. The company anticipates,that these ... the NASDAQ,stock market opens on May 12, 2008., ...
... May 7 AMDL, Inc. (Amex: ... in Shenzhen, Jiangxi,and Jilin, China, is a ... its subsidiary Jade Pharmaceutical Inc. (JPI),the Company ... of diagnostic, pharmaceutical, nutritional supplement, and,cosmetic products., ...
Cached Medicine News:Health News:Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies 2Health News:Obesity can increase dementia risk by up to 80 percent 2Health News:Nursing Shortage Spurs Campaign to Change the Image of Nursing in the Media 2Health News:Emageon Inc. to Host First Quarter 2008 Financial Results Conference Call May 12, 2008 2Health News:AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company 2Health News:AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: